NEW PRODUCTS

[BIOSIMILAR] InVivoSIM™ Antibodies

관리자 2021-03-17 Views 980

BIOSIMILAR RESEARCH GRADE ANTIBODIES

What Are InVivoSIM Antibodies?

Bio X Cell InVivoSIM™ antibodies are research-grade biosimilar monoclonal antibodies. Each biosimilar antibody is produced using recombinant technology and incorporates the same variable region sequence as the original pharmaceutical drug. 

Biosimilar antibodies make it possible to study the biological effects of a drug without needing to source expensive pharmaceutical-grade therapeutics. They can be used for many research applications including functional assays, flow cytometry, ELISA, Immunohistochemistry, pharmacokinetic assays, and others. 

InVivoSIM™ antibodies are offered with the same purity and in vivo formulations that Bio X Cell is known for. Our biosimilars are of exceptional quality and consistency. They are ultra-pure and free of preservatives, stabilizers, and carrier proteins, making them ideal for in vivo applications including drug efficacy studies in humanized mouse models.

 

InVivoSIM™ Biosimilar Antibodies Feature

  • Exceptional Purity Each lot is QC tested for purity using SDS-PAGE and are preservative, stabilizer, and carrier protein-free.
  • Binding Validation Each lot of InVivoSIM™ product is validated for antigen binding by immunoblot.
  • Ultra-low Endotoxin Levels The level of endotoxin is QC tested for each lot. Our InVivoSIM™ products are ≤ 1EU/mg. If endotoxin levels below 1EU/mg are required, please contact technical support to discuss your needs.
  • Pathogen Free Each lot of InVivoSIM™ product is screened for an exhaustive panel of murine pathogens. The results are detailed on product-specific datasheets, to help you adhere to IACUC and Animal Facility requirements.
  • Low Protein Aggregation Each lot of InVivoSIM™ product is QC tested for aggregate level and guaranteed to be below 5% of the total protein.

 

InVivoSIM™ Antibodies are for Research Use Only (RUO) and NOT FOR THERAPEUTIC USE.


Product NameHostIsotypeCatalog NumberRecommended Isotype Control
InVivoSIM Anti-Human TNFα (Adalimumab Biosimilar)HumanHuman IgG1SIM0001InVivoPlus Human IgG1 Isotype Control
InVivoSIM Anti-Human EGFR (Cetuximab Biosimilar)HumanHuman IgG1SIM0002InVivoPlus Human IgG1 Isotype Control
InVivoSIM Anti-Human PD-1 (Nivolumab Biosimilar)HumanHuman IgG4SIM0003InVivoMAb Human IgG4 (S228P) Isotype Control, Anti-Hen Egg Lysozyme
InVivoSIM Anti-Human CTLA-4 (Ipilimumab Biosimilar)HumanHuman IgG1SIM0004InVivoPlus Human IgG1 Isotype Control
InVivoSIM Anti-Human HER2 (Trastuzumab Biosimilar)HumanHuman IgG1SIM0005InVivoPlus Human IgG1 Isotype Control
InVivoSIM Anti-Human TNFα (Infliximab Biosimilar)HumanHuman IgG1SIM0006InVivoPlus Human IgG1 Isotype Control
InVivoSIM Anti-Human VEGF (Bevacizumab Biosimilar)HumanHuman IgG1SIM0007InVivoPlus Human IgG1 Isotype Control
InVivoSIM Anti-Human CD20 (Rituximab Biosimilar)HumanHuman IgG1SIM0008InVivoPlus Human IgG1 Isotype Control
InVivoSIM Anti-Human PD-L1 (Atezolizumab Biosimilar)HumanHuman IgG1SIM0009InVivoPlus Human IgG1 Isotype Control
InVivoSIM Anti-Human PD-1 (Pembrolimumab Biosimilar)HumanHuman IgG4SIM0010InVivoMAb Human IgG4 (S228P) Isotype Control, Anti-Hen Egg Lysozyme
InVivoSIM Anti-Human C5 (Eculizumab Biosimilar)HumanHuman IgG4SIM0011InVivoMAb Human IgG4 (S228P) Isotype Control, Anti-Hen Egg Lysozyme
InVivoSIM Anti-Human VEGFR-2 (Ramucirumab Biosimilar)HumanHuman IgG1SIM0012InVivoPlus Human IgG1 Isotype Control
InVivoSIM Anti-Human IL-17A (Secukinumab Biosimilar)HumanHuman IgG1SIM0013InVivoPlus Human IgG1 Isotype Control
InVivoSIM Anti-Human IL-6R (Tocilizumab Biosimilar)HumanHuman IgG1SIM0014InVivoPlus Human IgG1 Isotype Control